Back to Dashboard
JNJ · Healthcare

Johnson & Johnson

USA Healthcare Filing: 2026-03-31
37/100
Smart-money confidence1 of 3 sources positive
Weak — few signals

company insiders are selling

Hedge funds
66
Congress
No data
Insiders
0
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$627.4B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About JOHNSON & JOHNSON

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of…

Who's behind the signal
Every informed buyer we can see on JNJ, across all three feeds.
Hedge funds · 11
Soros Fund Management (Soros) New position
Citadel Advisors Increased +146%
Tweedy Browne Decreased −7%
Markel Group (Tom Gayner) Unchanged
Bridgewater Associates (Dalio) Decreased −47%
AQR Capital Management Decreased −9%
+5 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
Company insiders Selling
Recent sells15
Congressional trades · 50 on record
Disclosures from 2020-06-29 to 2024-10-29
The newest disclosure we hold for this stock is 2024-10-29. That is the end of our data, not necessarily the end of the trading — our bulk STOCK Act archive stops there and newer filings arrive through a separate live feed. Treat the absence of recent rows as “not covered”, not as “no trades”.
Trade date Member Chamber Action Amount
2024-10-29 Tommy Tuberville · R-AL Senate Sold $15,001 - $50,000
2022-09-12 Kathy E. Manning · D-NC House Sold $1,001 - $15,000
2022-06-28 John R. Curtis · R-UT House Bought $1,001 - $15,000
2022-06-08 Diana Harshbarger · R-TN House Bought $1,001 - $15,000
2022-06-07 Lloyd Doggett · D-TX House Bought $1,001 - $15,000
2022-06-07 Kevin Hern · R-OK House Bought $1,001 - $15,000
2022-05-04 Lois Frankel · D-FL House Sold $1,001 - $15,000
2022-05-04 Cynthia Axne · D-IA House Sold $1,001 - $15,000
2022-04-25 Lois Frankel · D-FL House Sold $1,001 - $15,000
2022-03-09 John R. Curtis · R-UT House Bought $1,001 - $15,000
Show the other 40
Trade date Member Chamber Action Amount
2022-03-08 Kevin Hern · R-OK House Bought $1,001 - $15,000
2022-01-18 Pete Sessions · R-TX House Sold $15,001 - $50,000
2021-12-07 Kevin Hern · R-OK House Bought $1,001 - $15,000
2021-09-13 Robert J. Wittman · R-VA House Sold $1,001 - $15,000
2021-09-10 Austin Scott · R-GA House Sold $15,001 - $50,000
2021-09-10 Robert J. Wittman · R-VA House Sold $1,001 - $15,000
2021-09-07 Kevin Hern · R-OK House Bought $1,001 - $15,000
2021-09-02 Kevin Hern · R-OK House Bought $50,001 - $100,000
2021-07-06 Alan S. Lowenthal · D-CA House Sold $1,001 - $15,000
2021-06-25 Kevin Hern · R-OK House Bought $250,001 - $500,000
2021-06-08 Kurt Schrader · D-OR House Sold $1,001 - $15,000
2021-05-04 Rick W. Allen · R-GA House Bought $15,001 - $50,000
2021-04-30 Kathy E. Manning · D-NC House Sold $1,001 - $15,000
2021-04-30 Blake D. Moore · R-UT House Bought $1,001 - $15,000
2021-04-23 Marie Newman · D-IL House Sold $15,001 - $50,000
2021-04-13 Marie Newman · D-IL House Bought $15,001 - $50,000
2021-03-26 Blake D. Moore · R-UT House Bought $1,001 - $15,000
2021-03-04 Carol D. Miller · R-WV House Bought $15,001 - $50,000
2021-03-04 Blake D. Moore · R-UT House Bought $1,001 - $15,000
2021-02-25 Blake D. Moore · R-UT House Bought $1,001 - $15,000
2021-02-24 Blake D. Moore · R-UT House Bought $1,001 - $15,000
2021-02-16 Peter Meijer · R-MI House Sold $15,001 - $50,000
2021-02-05 Kurt Schrader · D-OR House Bought $1,001 - $15,000
2021-01-26 Austin Scott · R-GA House Bought $15,001 - $50,000
2021-01-15 Kathy E. Manning · D-NC House Bought $1,001 - $15,000
2021-01-04 Chris Jacobs · R-NY House Sold $1,001 - $15,000
2020-11-25 Kenny Marchant · R-TX House Sold $15,001 - $50,000
2020-11-19 Kenny Marchant · R-TX House Bought $15,001 - $50,000
2020-10-16 Kevin Hern · R-OK House Bought $1,001 - $15,000
2020-10-16 K. Michael Conaway · R-TX House Bought $50,001 - $100,000
2020-10-16 K. Michael Conaway · R-TX House Bought $15,001 - $50,000
2020-09-30 Josh Gottheimer · D-NJ House Bought $1,001 - $15,000
2020-09-08 Chris Jacobs · R-NY House Sold $15,001 - $50,000
2020-08-21 Jerry Moran · R-KS Senate Bought $1,001 - $15,000
2020-08-21 Bob Gibbs · R-OH House Bought $1,001 - $15,000
2020-08-10 K. Michael Conaway · R-TX House Bought $15,001 - $50,000
2020-07-28 Carol D. Miller · R-WV House Bought $15,001 - $50,000
2020-07-27 Kevin Hern · R-OK House Bought $1,001 - $15,000
2020-07-23 Josh Gottheimer · D-NJ House Bought $1,001 - $15,000
2020-06-29 William R. Timmons IV · R-SC House Sold $1,001 - $15,000
Not a model pick — but on our radar. JOHNSON & JOHNSON isn't in the top-10 model right now, but 11 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
11
Investors
1
New positions
1
Increasing
7
Decreasing
2
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Soros Fund Management (Soros)
Trust weight: 1.5×
New position
% of portfolio
0.1%
Position change
NEW
0.1% of Soros Fund Management's portfolio
Citadel Advisors
Trust weight: 1.0×
Increased +146%
% of portfolio
0.3%
Position change
+146%
0.3% of Citadel Advisors's portfolio
Tweedy Browne
Trust weight: 1.2×
Decreased −7%
% of portfolio
4.3%
Position change
−7%
4.3% of Tweedy Browne's portfolio
Markel Group (Tom Gayner)
Trust weight: 1.4×
Unchanged
% of portfolio
1.2%
Position change
—
1.2% of Markel Group's portfolio
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Decreased −47%
% of portfolio
0.8%
Position change
−47%
0.8% of Bridgewater Associates's portfolio
AQR Capital Management
Trust weight: 1.0×
Decreased −9%
% of portfolio
0.4%
Position change
−9%
0.4% of AQR Capital Management's portfolio
Polen Capital Management
Trust weight: 1.3×
Decreased −4%
% of portfolio
0.3%
Position change
−4%
0.3% of Polen Capital Management's portfolio
Elliott Investment Mgmt
Trust weight: 1.3×
Unchanged
% of portfolio
0.3%
Position change
—
0.3% of Elliott Investment Mgmt's portfolio
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Decreased −5%
% of portfolio
0.2%
Position change
−5%
0.2% of Gotham Asset Mgmt's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Decreased −14%
% of portfolio
0.2%
Position change
−14%
0.2% of D.E. Shaw & Co's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Decreased −38%
% of portfolio
0.1%
Position change
−38%
0.1% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to JOHNSON & JOHNSON
No insider trades found in the last 90 days
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell JOHNSON & JOHNSON or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API